Description: Panagene Inc. develops products in the field of molecular diagnostics in South Korea. Its products include Liquid biopsy products for lung and colon cancers; tissue biopsy products for lung, thyroid, pancreatic, and colon cancers, as well as glioblastoma, myeloproliferative neoplasm, chronic myelogenous leukemia, central nervous system, myelofibrosis, and polycythemia vera diseases. The company also offers products for cervical cancer, sexually transmitted, and extreme drug resistance diseases; and peptide nucleic acid products. The company was formerly known as Koram Panagene Ltd. and changed its name to Panagene Inc. in January 2009. Panagene Inc. was incorporated in 1976 and is based in Daejeon, South Korea.
Home Page: www.panagene.com
54, Techno 10-ro
Daejeon,
34027
South Korea
Phone:
82 4 2861 9295
Officers
| Name | Title |
|---|---|
| Byung-Hoon Lee | Managing Director |
| Tae-Sung Kim | Managing Director |
| Goon-Ho Cho | Exec. |
| Sang-Yong Park | Exec. |
| Sung-Ki Kim | Chief Exec. Officer and Pres |
| Dal-Soo Kim | Head of Marketing |
| Hee-Kyung Park | Head of Laboratory and Managing Director |
| Won-Yong Go | Head of Information management |
| Ji-Hwan Jang | Exec. |
| Jin-Haeng Lee | Exec. |
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 3.4253 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 63 |